---
title: Lambda Therapeutic Research vs Pharmaron
slug_a: lambda-cro
slug_b: pharmaron
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lambda-cro/pharmaron
---

# Lambda Therapeutic Research vs Pharmaron

Side-by-side profile data from each company listing on this directory.

## Lambda Therapeutic Research

- Profile: [/companies/lambda-cro](/companies/lambda-cro)

Lambda Therapeutic Research — Full-service global CRO offering Phase I–IV clinical trial management, pharmacovigilance, and bioanalytical labs, plus biologics CDMO services. Has supported 280+ clinical trials across 15+ therapeutic domains.

Services: 13. Modalities: 1. Indications: 10. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Bioanalysis
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Clinical Imaging Core Lab
- Regulatory Affairs

### Modalities

- Biologics (Other)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Pharmaron

- Profile: [/companies/pharmaron](/companies/pharmaron)

Pharmaron — Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

Services: 99. Modalities: 14. Indications: 14. Locations: 32. Certifications: 0. The strongest documented coverage currently appears in services (99).

### Services

- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- High-Throughput Screening
- Target Identification & Validation
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- GLP Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Analytical Method Development & Validation
- ICH Stability Studies
- CMC Analytical Development
- Process Development
- Formulation Development
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Cell-Line Development
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Technology Transfer
- Quality Control Testing
- Stability Testing & Storage
- Extractables & Leachables Studies
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Cold-Chain Storage & Logistics
- Combination Product Assembly & Final Packaging
- CMC Regulatory Submission Support
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Translational Research
- Companion Diagnostics Development
- Microbiology Services
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Pathology & Histology Services
- Proteomics Services
- Genomics & Sequencing Services
- Bioinformatics & Data Science
- Device & Combination Product Services
- Discovery Research

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- mRNA
- Cell Therapy
- Gene Therapy
- Peptide
- Vaccine
- Radiopharmaceutical
- Microbiome Therapeutic
- AAV / Viral Vector Platform
- Synthetic Biology

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Cartridges
- Oral Solid Dose (OSD)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Expression: Cell-Free
- Single-Use / Disposable
- Stainless Steel
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Flow Chemistry
- Cryogenic (−80 °C)